IN THE HIGH COURT OF NEW ZEALAND AUCKLAND REGISTRY
I TE KŌTI MATUA O AOTEAROA TĀMAKI MAKAURAU ROHE
CIV-2020-404-1080
[2021] NZHC 2441
UNDER the Copyright Act 1994 BETWEEN
ROYALE BIOTECH GROUP LIMITED
Plaintiff
AND
HI GLOBE INTERNATIONAL TRADING LIMITED
Defendant
Hearing: On the papers Counsel:
No appearance for the plaintiff JRE Wach for the defendant
Judgment:
17 September 2021
JUDGMENT OF JAGOSE J
[Costs]
This judgment was delivered by me on 17 September 2021 at 10.00am.
Pursuant to Rule 11.5 of the High Court Rules.
………………………… Registrar/Deputy Registrar
Solicitors:
James & Wells Solicitors – Auckland Branch
ROYALE BIOTECH GROUP LTD v HI GLOBE INTERNATIONAL TRADING LTD - Costs [2021] NZHC
2441 [17 September 2021]
[1] My 23 August 2021 judgment, striking out Royale Biotech’s claims as an abuse of process and declaring its proceeding abandoned, awarded costs to Hi Globe and reserved their quantification.1
[2] Hi Globe now seeks costs in the amount of $59,167.74, comprising 2B scale costs of $21,988.00 to the end of May 2021, during which Royale Biotech last took any step in this proceeding, and indemnity costs in the amount of $35,549.74 (including GST) thereafter (plus $1,620 disbursements). Royale Biotech makes no response.
[3] Given my finding Royale Biotech’s abuse of process was to “use [this] proceeding effectively to prevent release of the bottles to Hi Globe”,2 its conduct meets the statutory threshold for indemnity costs.3 It was “distinctly bad behaviour”,4 constituting the “flagrant” or “very unreasonable” misconduct threshold for consideration of indemnity costs.5 Assuming Hi Globe to be GST-registered, GST is not recoverable.6
[4]I therefore order Royale Biotech pay Hi Globe costs in the amount of
$54,309.50 (comprised by 2B scale costs of $21,988.00 and indemnity costs in the amount of $30,912.80 (plus $1,408.70 disbursements)).
—Jagose J
1 Royale Biotech Group Ltd v Hi Globe International Trading Ltd [2021] NZHC 2176 at [13]–[14].
2 At [8].
3 High Court Rules 2016, r 14.6(4).
4 Bradbury v Westpac Banking Corporation [2009] 3 NZLR 400 (CA) at [26].
5 Prebble v Huata (No 2) [2005] NZSC 18, [2005] 2 NZLR 467 at [6]; and Flujo Holdings Pty Ltd v Merisant Co Inc [2018] NZCA 226 at [34].
6 New Zealand Venue and Event Management Ltd v Worldwide NZ LLC [2016] NZCA 282, (2016) 27 NZTC 22-058 at [17]. See also High Court Fees Regulations 2013, reg 24.
- AGLC
- Royale Biotech Group Limited v Hi Globe International Trading Limited [2021] NZHC 2441
- Case
- [2021] NZHC 2441
- Decision Date
CaseChat Overview and Summary
The central legal issue was the assessment of costs incurred by Hi Globe, which sought $59,167.74. This amount included both 2B scale costs up until May 2021 and indemnity costs thereafter. Royale Biotech did not respond to Hi Globe's claim for costs. The court had to determine whether the costs claimed by Hi Globe were justified, particularly in light of the finding that Royale Biotech's actions constituted an abuse of process. The court concluded that Hi Globe's conduct met the statutory threshold for indemnity costs, as it was distinctly bad behaviour and constituted the "flagrant" or "very unreasonable" misconduct required for such costs.
The court found that Royale Biotech's abuse of process was intended to prevent the release of the bottles to Hi Globe. This finding supported the imposition of indemnity costs, which are awarded for conduct that is notably worse than mere negligence. The court ordered Royale Biotech to pay Hi Globe $54,309.50, which included both 2B scale and indemnity costs, minus the amount of GST, as it was not recoverable. This decision reflects the court's view that the misconduct by Royale Biotech was severe enough to warrant indemnity costs.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.